🇺🇸 FDA
Patent

US 12209140

Therapeutics for the treatment of glaucoma

granted A61KA61K31/353A61K31/4025

Quick answer

US patent 12209140 (Therapeutics for the treatment of glaucoma) held by Regents of the University of Minnesota expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/353, A61K31/4025, A61K31/4439, A61K31/454